FAHJRI SAPUTRA

1310311063

I N T R A V E N O U S LY A D M I N I S T E R E D V I TA M I N
C A S C A N C E R T H E R A P Y: T H R E E C A S E S

SUMMARY
Early clinical studies showed that high-dosevitamin
C, given by intravenous and oral routes, may improve
symptoms and prolong life in patients with
terminalcancer.
Vitamin Cis toxic to somecancercells but not to
normal cells in vitro, where patients had
unexpectedly long survival times after receiving
high-dose intravenousvitamin Ctherapy.
The role of high-dose intravenousvitamin Ctherapy
incancer treatmentshould be reassessed.

SOMETHING THAT I GET FROM

THIS JOURNAL
Intravenous

administration of the
maximum tolerated dose ofvitamin
Cproduces plasma levels 25 times
that achieved when the same dose
is administered orally. At high
plasma concentrationsvitamin Cis
toxic to somecancercells but not to
normal cells in vitro.

 There were 3 researches to 3 different

patient that advanced cancerwhere
patients had unexpectedly long survival
times
after
receiving
high-dose
intravenousvitamin C therapy. It can
prove that vitamin C in high dose can
be
anti-tumour
effects
in
certaincancers.

I READ 3 ARTICLES

1. Intravenously administered vitamin C as

cancer therapy: three cases (Tamayo,
Carmen;Richardson, Mary Ann, 2003: 94101)

I choose
this
journal

2. Cancer Therapy; Researchers

study whether high-dose
vitamin C can be used as a
cancer therapy (Mayo Clinic,
2006: 342)

3. Vitamin C as a cancer treatment: State

of the science and recommendations
for research (Padayatty, Sebastian J;
Riordan, Hugh D; Hewitt, Stephen M;
Katz, Arie; et al, 2006: 37-42)

Why I Choose Article

No. 1?

Because im very interested a news about

something that i never read before.
And the no.1 article, the author prove
their subject by doing experiment to the
patient
This article is easier to understand for me

TETAP
BELAJAR!!